News GSK plc Deutsche Boerse AG

Equities

GS71

GB00BN7SWP63

Market Closed - Deutsche Boerse AG Other stock markets 01:11:18 27/04/2024 am IST			5-day change	1st Jan Change
19.15 ^EUR	+0.52%		+3.79%	+14.78%

25/04	Sector Update: Health Care Stocks Drop in Afternoon Trading	MT
25/04	GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Drop in Afternoon Trading	25/04	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	25/04	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	25/04	MT
GSK Files Lawsuit Against Pfizer, BioNTech Over mRNA Patents Infringement	25/04	MT
Moody’s Affirms Haleon’s Ratings on Strong Operating Performance	25/04	MT
CureVac Begins Early Stage Portion of Investigational Vaccine Trial	24/04	MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	24/04
GSK's Application for Jemperli's Expanded Indication Accepted by FDA for Priority Review	24/04	MT
CureVac, GSK Launch Phase 1/2 Trial of Bird Flu Vaccine Candidate	24/04	MT
GSK : Gets a Sell rating from JP Morgan	24/04	ZD
GSK : Gets a Buy rating from Bernstein	24/04	ZD
US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer \| GSK	24/04	AQ
GSK plc Announces the US Food and Drug Administration Accepted the Supplemental Biologics License Application for Jemperli	24/04	CI
GSK: FDA priority review for endometrial cancer	24/04	CF
GSK's Jemperli with chemotherapy accepted for priority review by FDA	24/04	AN
GSK Secures US FDA's Priority Review for Expanded Use of Endometrial Cancer Treatment	24/04	MT
GSK Says U.S. FDA Accepts New Indication Filing For Jemperli	24/04	RE
Edwards Lifesciences Corporation: The story continues	23/04
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	22/04	MT
GSK : Director/Pdmr Shareholding - Form 6-K	19/04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : 2023 ended on a strong note; medium- to long-term guidance raised

February 02, 2024 at 08:10 pm IST